Amerikanische Gesellschaft für Hirudotherapie

Governance-Dashboard

Operative Ergebnisse des ASH-Redaktionssystems. Verifizierbare Governance-Metriken — niemals Behauptungen klinischer Ergebnisse, die ASH zugeschrieben werden.

ASH organizational governanceInstitutional reference

792

Total registry entries

across 5 atlases

400

Pages with reviewedBy

ASH Editorial Board

289

Citations verified

PubMed PMIDs + DOIs

4

Localized languages

EN / RU / ES / DE

Editorial discipline

Tier A/B condition standardization

13/13

High-clinical-risk condition pages with full structured patient summary, reviewedBy metadata, and FDA boundary classification.

Tier A: 3 FDA-cleared (K040187 microsurgical flap salvage and replantation contexts)
Tier B: 10 RCT-supported off-label

Translation-limit closure

201/201

Compound profile pages with explicit clinical-translation-limit statement preventing misreading of mechanistic findings as treatment claims.

Closes Cycle 05 audit gap (116/160 pages historically lacked this signal).

Drug-vs-leech disambiguation

201/201

Compound entries explicitly classified as whole-leech vs leech-derived vs purified vs recombinant vs synthetic-analog. Prevents conflation of FDA-approved derivatives with whole-leech therapy.

Honest regulatory uncertainty

113/155

Jurisdictions with no verified leech-specific regulatory framework explicitly marked as "unregulated" rather than inflated to a status we cannot defend.

Citation depth

142

RCT PubMed IDs verified

of 169 trials in registry

169

RCTs with GRADE rating

GRADE Working Group methodology

201

Biographical publications

across 68 figures

What this page shows — and does NOT show

All metrics above are operational outputs of the editorial system: counts of pages reviewed, citations verified, and fields populated. They are independently verifiable against the public registries and git history.

This dashboard does NOT claim ASH-attributed clinical outcomes.We do not show "X patients helped" or "Y limbs saved" — those are published-literature outcomes belonging to the trials we curate, not to ASH.

Clinical outcomes can only be cited as published literature outcomes with full citation, sample size, and limitations — never as ASH institutional achievements.

Drill-down to source registries

All metrics computed at build time from public registries. View source: github.com/RondvS/ash-website/lib.

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.

Governance Dashboard — Operational Outputs | ASH | Amerikanische Gesellschaft für Hirudotherapie